⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VRCA News
Verrica Pharmaceuticals Inc. Common Stock
Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting
globenewswire.com
VRCA
Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
VRCA
VRCA Investors Have the Opportunity to Join Investigation of Verrica Pharmaceuticals Inc. with the Schall Law Firm
businesswire.com
VRCA
VRCA Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA
businesswire.com
VRCA
Verrica Pharmaceuticals Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA
businesswire.com
VRCA
Form 8-K
sec.gov
VRCA
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
VRCA
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026
globenewswire.com
VRCA
Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
globenewswire.com
VRCA
Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer
globenewswire.com
VRCA